In The News

• Compugen Cancer Target Results Demonstrate Significant Potential for Cancer Immunotherapy
  by BUSINESS WIRE. February 2, 2012
• Compugen Presents Three Product Candidates for Treatment of Autoimmune Diseases at the Immunotherapeutics & Immunomonitoring Conference
  by BUSINESS WIRE. January 30, 2012
• D. Medical Signs Fifth U.S Distribution Agreement for Spring Universal Infusion Sets
  TASE. January 25, 2012
• BioLineRx Signs Exclusive License Agreement for BL-8020, an Oral Treatment for Hepatitis C
  TASE. January 24, 2012
• Oramed Pharmaceuticals Granted Australian Patent for Important Part of the Company's Core Technology in Oral Delivery of Proteins
  by Oramed Pharmaceuticals. January 24, 2012
• The Ministry of Finance and OCS Promote of Research and Development in Israel's Life Sciences Industry
  Press Release. January 23, 2012
• Oridion - FDA Import Alert Modification
  by Oridion Systems Ltd. . January 23, 2012
• Pluristem Awarded a $2.4 Million Grant from Israeli Government
  by GlobeNewswire. January 18, 2012
• Expansion of D. Medical’s U.S Distribution Network for Spring Universal Infusion Sets Continues
  TASE. January 17, 2012
• D. Medical Receives CE Mark Approval for “Spring Zone” Durable Insulin Pump
  TASE. January 11, 2012